Event-Driven Stocks

HeartSciences Inc.

HSCSNasdaq

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · TX · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 1 good● 5 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22
Revenue$4,350$18,600$5,150$14,373
Operating income−$8.4M−$6.3M−$6.1M−$4.7M
Net income−$8.8M−$6.6M−$6.4M−$4.8M
Total assets$4.2M$9.5M$3.3M$2.1M
Total liabilities$4.0M$2.2M$3.1M$8.1M
Equity$205,171$7.3M$230,557−$6.1M
EPS (diluted)$-9.34$-18.74$-80.00$-1.45
Shares out.1.9M855,96610.4M3.3M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−192013.1%
Net margin
−201499.5%
Return on equity
−4272.2%
Return on assets
−207.6%
Return on capital (ROCE)
−1607.2%
Liabilities / assets
95.1%
Debt / equity
19.58×
Book value / share
$0.11
Revenue growth (YoY)
−76.6%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-74.39distress
Accruals / assets
−32.0%clean
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
25
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 67Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 5 warning● 1 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202637,6721.4+19.0%
Apr 30, 202631,6471.0+10.0%
Apr 15, 202628,7782.0-18.2%
Mar 31, 202635,1923.2+8.3%
Mar 13, 202632,4983.5-14.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)